Black Diamond Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Black Diamond Therapeutics Inc
TickerBDTX
CIK #0001701541
CUSIP09203E105
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address139 Main Street, Cambridge, MA 02142
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Black Diamond Therapeutics Inc 2019-12-06 85.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
ASET Therapeutics Inc 2017-03-28 12.1 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001701541] 10-K
[0001701541] 10-Q
[0001701541] 3
[0001701541] 4
[0001701541] 8-K
[0001701541] D
[0001701541] SC 13D
[0001701541] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vestal Point Capital LP Black Diamond Therapeutics Inc [2024-11-14] 8.9
BlackRock Inc Black Diamond Therapeutics Inc [2024-11-08] 6.2
BlackRock Inc Black Diamond Therapeutics Inc [2024-10-24] 6.2
T Rowe Price Investment Management Inc Black Diamond Therapeutics Inc [2024-02-14] 7.6
BlackRock Inc Black Diamond Therapeutics Inc [2022-07-08] 3.5
BlackRock Inc Black Diamond Therapeutics Inc [2022-02-04] 6.2
BB Biotech AG Black Diamond Therapeutics Inc [2021-02-11] 5.3
Vanguard Group Inc Black Diamond Therapeutics Inc [2021-02-10] 5.13
Boxer Capital LLC Black Diamond Therapeutics Inc [2020-02-13] 0.0
New Enterprise Associates 16 LP Black Diamond Therapeutics Inc [2020-02-13] 0.6
Versant Venture Capital VI LP Black Diamond Therapeutics Inc [2020-02-13] 11.0
RA Capital Management LP Black Diamond Therapeutics Inc [2020-02-05] 7.2
Flynn James E Black Diamond Therapeutics Inc [2020-02-03] 2.27
Form 3/4/5 Filer 2011 - 2026
Dhingra Kapil
Black Diamond Therapeutics Inc
Kulkarni Samarth
Raman Prakash
Campbell Shannon
Menzel Garry E
Behbahani Ali
Jones Erika
Hatzis-Schoch Brent
Velleca Mark A
Buck Elizabeth
Yurasov Sergey
BB Biotech AG
Biotech Growth N V
Versant Vantage I LP
Versant Voyageurs I Parallel LP
Versant Voyageurs I LP
Versant Venture Capital VI LP
Dixon Wendy L
Ni Fang
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Management LP
RA Capital Nexus Fund LP
Kolchinsky Peter
Epstein David M
Mayweg Alexander
Ingram Robert Alexander
Bolzon Bradley J PhD
Roberts Christopher D
Humphrey Rachel
Leggett Thomas
Wellington Biomedical Innovation Master Investors Cayman I
Deerfield Management Company LP
Deerfield Capital LP
Deerfield Partners LP
Flynn James E
Walker Paul Edward
Sonsini Peter W
Sandell Scott D
Mott David M
Makower Joshua
Makhzoumi Mohamad
Florence Anthony A Jr
Chang Carmen
Baskett Forest
NEA Partners 16 LP
New Enterprise Associates 16 LP
NEA 16 GP LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Behbahani Ali
Common Stock
2026-03-20 Grant 6,919 $2.15 14,876
Raman Prakash
Common Stock
2026-03-20 Grant 6,105 $2.15 13,126
Yurasov Sergey
Stock Option (Right to Buy) · derivative
2026-01-21 Grant 250,000 $0.00
Hatzis-Schoch Brent
Stock Option (Right to Buy) · derivative
2026-01-21 Grant 250,000 $0.00
Buck Elizabeth
Stock Option (Right to Buy) · derivative
2026-01-21 Grant 250,000 $0.00
Jones Erika
Stock Option (Right to Buy) · derivative
2026-01-21 Grant 200,000 $0.00
Velleca Mark A
Stock Option (Right to Buy) · derivative
2026-01-21 Grant 600,000 $0.00
Raman Prakash
Common Stock
2025-12-12 Grant 4,665 $2.76 12,875
Behbahani Ali
Common Stock
2025-12-12 Grant 5,208 $2.76 14,374
Common Stock
2025-09-19 Grant 4,291 $3.35 14,375
Common Stock
2025-09-19 Grant 3,843 $3.35 12,874
Behbahani Ali
Common Stock
2025-06-20 Grant 6,170 $2.33 14,376
Raman Prakash
Common Stock
2025-06-20 Grant 5,526 $2.33 12,876
Kulkarni Samarth
Stock Option (Right to Buy) · derivative
2025-06-12 Grant 30,550 $0.00
Campbell Shannon
Stock Option (Right to Buy) · derivative
2025-06-12 Grant 30,550 $0.00
Behbahani Ali
Stock Option (Right to Buy) · derivative
2025-06-12 Grant 30,550 $0.00
Raman Prakash
Stock Option (Right to Buy) · derivative
2025-06-12 Grant 30,550 $0.00
Dhingra Kapil
Stock Option (Right to Buy) · derivative
2025-06-12 Grant 30,550 $0.00
Menzel Garry E
Stock Option (Right to Buy) · derivative
2025-06-12 Grant 30,550 $0.00
Raman Prakash
Common Stock
2025-03-21 Grant 6,848 $1.88 12,874
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 104 25,774,305
2025-12-31 105 25,987,431
2025-09-30 92 28,116,608
2025-06-30 95 28,205,538
2025-03-31 88 30,457,429
2024-12-31 90 37,520,198
2024-09-30 104 40,911,326
2024-06-30 92 36,260,494
2024-03-31 89 32,749,719
2023-12-31 78 35,059,401
2023-09-30 74 35,256,399
2023-06-30 76 41,852,587
Form 13F Holdings
Firm Period DFND Voting Shares
Diversified Trust Co [2026-06-30] SOLE 0 18,860
DLK Investment Management LLC [2026-06-30] SOLE 16,215 16,215
Brookstone Capital Management [2026-06-30] SOLE 0 13,484
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com